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Abstract: A series of new 4-aryl-2’-[(4-hydroxyphenyl)thio]-6oxo-1,6-dihydro-
2,4’-bipyridine-5-carbonitriles (3a–k) and 6-amino-4aryl-2’-[(4-hydroxyphe-
nyl)thio]-2,4’-bipyridine-5-carbonitriles (4a–h) were synthesized from 4-hydro-
xythiophenol (1). The reaction of 4-hydroxythiophenol with 4-acetyl-2-chloro-
pyridine yielded 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2). Further 
treatment of 2 with ethyl cyanoacetate in the presence of ammonium acetate 
with various aromatic aldehydes furnished the compounds 3a–k. On the other 
hand, condensation of 2 with aromatic aldehydes in the presence of alcoholic 
malononitrile in ammonium acetate gave compounds 4a–h. The structures of 
the newly synthesized compounds were established on the basis of their 
elemental analysis, as well as their IR, 1H- and 13C-NMR and mass spectral 
data. All the title compounds were subjected to in vitro antibacterial testing 
against two strains and antifungal screening against two fungi. Some of the 
compounds showed promising activity. 
Keywords: 2,4’-bipyridine-5-carbonitriles; 3-cynopyridines; antibacterial; antifungal. 
INTRODUCTION 
The pyridine skeleton is of great importance to chemists as well as to bio-
logists as it is found in a large variety of naturally occurring compounds and also 
in clinically useful molecules having diverse biological activities. Its derivatives 
are known to possess antitubercular,1 anti-ulcer,2 antimicrobial,3–6 antineoplas-
tic,7 antitumor,8–12 antiviral13 and cardiotonic14 properties. It has been well es-
tablished that the presence of biologically active thiophenols is an important 
structural feature of a variety of synthetic drugs.15–21 Encouraged by the above 
reports, it was planned to synthesize new 2,4’-bipyridine-5-carbonitriles carrying 
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the 4-hydroxyphenylthio moiety, aiming at an investigation of new heterocycles 
of enhanced pharmacological activities. The present study describes the synthesis 
of hitherto unreported 4-aryl-2’-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4’-
-bipyridine-5-carbonitriles (3a–k) and 6-amino-4-aryl-2’-[(4-hydroxyphenyl)-
thio]-2,4’-bipyridine-5-carbonitriles (4a–h) and an evaluation of their in vitro 
antibacterial and antifungal activities. 
RESULTS AND DISCUSSION 
Chemistry 
The reaction sequences employed for the synthesis of the title compounds is 
shown in Scheme 1. The key intermediate, 1-{2-[(4-hydroxyphenyl)thio]pyridin-
-4-yl}ethanone (2), required for the preparation of the target compounds was ob-
tained by the condensation 4-hydroxythiophenol (1) with 2-chloro-4-acetylpyri-
dine in pyridine medium. The compound 2 on treatment with aromatic aldehydes 
in presence of ethyl cyanoacetate and ammonium acetate in ethanolic medium 
yielded the compounds 4-aryl-2’-[(4-hydroxyphenyl)thio]-6oxo-1,6-dihydro-2,4’- 
-bipyridine-5-carbonitriles (3a–k). On the other hand, condensation of 2 with aro-
matic aldehydes in presence of alcoholic malononitrile in ammonium acetate 
gave 6-amino-4-aryl-2’-[(4-hydroxyphenyl)thio]-2,4’-bipyridine-5-carbonitriles 
(4a–h). 
 
Scheme 1. The synthesis of the title compounds. 
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The structural elucidations of new compounds were based on their elemental 
analysis and spectral (IR, 1H- and 13C-NMR and mass) data. The characteri-
zation data of all the new compounds are summarized in Table I and their spec-
tral data are given below. 
TABLE I. Characterization data of compounds 3a–k and 4a–h 
Compd. Aromatic  moiety  Molecular 
formula 
Yield
% 
M.p.
°C 
Elemental analysis 
Found (Calcd.), % 
C H N 
3a  Phenyl C23H15N3O2S 397.5 >260 70.00 
(69.50)
3.91 
(3.80) 
10.80 
(10.57) 
3b  4-Chlorophenyl C23H14ClN3O2S 432 >260  64.00 
(63.96)
3.33 
(3.27) 
10.00 
(9.73) 
3c  3,4-Dimethoxyphenyl C25H19N3O4S 457.5  238–240 65.70 
(65.63)
4.25 
(4.19) 
9.20 
(9.18) 
3d  3-Hydroxy-4-me-
thoxyphenyl 
C24H17N3O4S 443.5 >260 65.50 
(65.00)
3.90 
(3.86) 
9.52 
(9.48) 
3e  4-N,N-Diethylamino- 
-2-hydroxyphenyl 
C27H24N4O3S 484.5 >260 67.00 
(66.92)
5.02 
(4.99) 
11.60 
(11.56) 
3f  4-Methylphenyl C24H17N3O2S 411.5 >260 70.10 
(70.05)
4.18 
(4.16) 
10.24 
(10.21) 
3g  4-Methoxyphenyl C24H17N3O3S 427.5 >260 67.50 
(67.43)
4.00 
(4.01) 
9.85 
(9.83) 
3h  4-Biphenylyl C29H19N3O2S 473.5 >260 73.60 
(73.55)
4.10 
(4.04) 
8.90 
(8.87) 
3i  2-Amino-3-pyridyl C22H15N5O2S 413.5 >260 64.00 
(63.91)
3.70 
(3.66) 
17.00 
(16.94) 
3j  2,3,5-Trihydroxy-
phenyl 
C23H15N3O5S 445.5 >260 62.08 
(62.02)
3.42 
(3.39) 
9.50 
(9.43) 
3k   6-Methoxy-2-naphthyl C28H19N3O3S 477.5  250–252 70.50 
(70.42)
4.00 
(4.01) 
8.84 
(8.80) 
4a  4-Chlorophenyl C23H15ClN4OS 431  230–232 64.14 
(64.11)
3.54 
(3.51) 
13.10 
(13.00) 
4b  4-Methoxyphenyl C24H17N4O2S 426.5  210–12 67.62 
(67.59)
4.28 
(4.25) 
13.20 
(13.14) 
4c  3,4-Dimethoxyphenyl C25H20N4O3S 456.5  205–07 65.80 
(65.77)
4.46 
(4.42) 
12.30 
(12.27) 
4d  4-Methylphenyl C24H18N4OS 410.5  230–32 70.30 
(70.22)
4.45 
(4.42) 
13.70 
(13.65) 
4e  3-Hydroxy-4-me-
thoxyphenyl 
C24H18 N4O3S 442.5 >260 65.20 
(65.14)
4.12 
(4.10) 
12.70 
(12.66) 
4f  4-Biphenylyl C29H20N4OS 472.5 >260 73.80 
(73.71)
4.30 
(4.27) 
11.90 
(11.86) 
4g  2-Amino-3-pyridyl C22H16N6OS 429.5 >260 64.00 
(64.06)
3.96 
(3.91) 
20.40 
(20.38) 
4h  2,3,5-Trihydroxy-
phenyl 
C23H16N4O4S 444.5 >260 59.80 
(59.73)
4.00 
(3.92) 
12.20 
(12.11) 
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2’-[(4-Hydroxyphenyl)thio]-6-oxo-4-phenyl-1,6-dihydro-2,4’-bipyridine-5-car-
bonitrile (3a). IR (KBr, cm–1):  2912 (ArH), 2218 (C=N), 1640
  (C=O), 1589
 
(C=C); 1H-NMR (DMSO-d6, δ / ppm): 6.90 (2H, d, C3–, C5–H of hydroxyphe-
nylthio), 7.41 (2H, d, C2–, C6–H of 4-hydroxyphenylthio), 7.60 (5H, m, aryl 
moiety), 7.70 (3H, m, of pyridines), 8.50 (1H, d, C6–H of pyridine moiety), 10.00 
(1H, s, phenolic OH), 13.00 (1H, s, NH of pyridine moiety). LC–MS (m/z): 398 
(M, 100 %). 
4-(4-Chlorophenyl)-2’-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4’-bipy-
ridine-5-carbonitrile (3b). IR (KBr, cm–1): 2903 (ArH), 2217(C=N), 1717 (C=O), 
1512 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 6.90 (2H, d, C3–, C5–H of hyd-
roxyphenylthio), 7.40 (2H, d, C2–, C6–H of hydroxyphenylthio), 7.55–7.75 (7H, 
m, aromatic protons of pyridines and aryl moiety), 8.50 (1H, d, C6–H of pyridine 
moiety), 10.00 (1H, s, phenolic OH), 13.00 (1H, s, NH of pyridine moiety); MS- 
-FAB (m/z): 432 (M+1, 100 %), 431(M, 20 %), 415 (M–OH). 
4-(3,4-Dimethoxyphenyl)-2’-[(4-hydroxyphenyl)thio]-6oxo-1,6-dihydro-2,4’- 
-bipyridine-5-carbonitrile (3c). IR (KBr, cm–1): 2882 (ArH), 2206 (C=N), 1716 
(C=O), 1498 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 3.80 (3H, s, OCH3), 3.90 
(3H, s, OCH3), 6.85 (m, 4H, C3–, C5–H of hydroxyphenylthio, C2–, C5–H of 
aryl), 7.18 (1H, d, C6–H of aryl), 7.36 (3H, m, aromatic protons of pyridines), 
7.42 (2H, d, C2–, C6–H of hydroxyphenylthio), 8.54 (1H, d, C6–H of pyridine), 
10.00 (1H, s, phenolic OH), 13.00 (1H, s, NH of pyridine); MS-FAB (m/z): 458 
(M+1, 100 %), 457 (M, 20 %). 
4-(3-Hydroxy-4-methoxyphenyl)-2’-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihyd-
ro-2,4’-bipyridine-5-carbonitrile (3d). IR (KBr, cm–1): 2854 (ArH), 2220 (C=N), 
1743 (C=O), 1515
 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 4.0 (3H, s, OCH3), 6.90 
(2H, d, C3–, C5–H of hydroxyphenylthio), 7.40 (4H, m, C2–, C5–H of aryl, C2–, 
C6–H of hydroxyphenylthio), 7.42 (3H, m, aromatic protons of pyridine), 8.6 
(1H, d, C6–H of pyridine moiety), 10.00 (1H, s, phenolic OH), 13.00 (1H, s, NH 
of pyridine moiety); MS-FAB (m/z): 444 (M+1, 100 %). 
4-(4-N,N-Diethylamino-2-hydroxyphenyl)-2’-[(4-hydroxyphenyl)thio]-6oxo-1,6- 
-dihydro-2,4’-bipyridine-5-carbonitrile (3e). IR (KBr, cm–1): 2954 (ArH), 2225 
(C=N), 1740 
(C=O), 1510 (C=C); MS-FAB (m/z): 485 (M+1, 100 %), 484 (M, 40 
%). 
2’-[(4-Hydroxyphenyl)thio]-4-(4-methylphenyl)-6-oxo-1,6-dihydro-2,4’-bipy-
ridine-5-carbonitrile (3f). IR (KBr, cm–1): 2913 (ArH), 2221 (C=N), 1638 (C=O), 
1489 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 2.40 (3H, s, CH3), 6.90 (2H, d, C3–, 
C5–H of hydroxyphenylthio), 7.35 (2H, d, C2–, C6–H of hydroxyphenylthio), 
7.44–7.60 (7H, m, aromatic protons of phenyl and pyridine), 8.5 (1H, d, C6–H of 
pyridine moiety), 9.90 (1H, s, phenolic OH), 12.90 (1H, s, NH of pyridine 
moiety). 
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2’-[(4-Hydroxyphenyl)thio]-4-(4-methoxyphenyl)-6-oxo-1,6-dihydro-2,4’-bi-
pyridine-5-carbonitrile (3g). IR (KBr, cm–1): 2903 (ArH), 2217 (C=N), 1717 
(C=O), 1512 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 3.85 (3H, s, OCH3), 6.90 
(2H, d, C3–, C5–H of hydroxyphenylthio), 7.10 (2H, d, C2–, C6–H of hydro-
xyphenylthio), 7.20 (2H, d, methoxyphenyl), 7.42 (2H, d, methoxyphenyl) 7.7 
(3H, m, pyridine), 8.5 (1H, d, C6–H of pyridine moiety), 12.90 (1H, s, phenolic 
OH), 13.00 (1H, s, NH of pyridine moiety). 
4-(4-Biphenylyl)-2’-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4’-bipyri-
dine-5-carbonitrile (3h). IR (KBr, cm–1): 2934 (CH3), 2221 (C=N), 1644 (C=O), 
1585 (C=C), 1489 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 6.90 (2H, d, C3–, C5–H 
of hydroxyphenylthio), 7.40 (2H, d, C2–, C6–H of hydroxyphenylthio), 7.45– 
–7.90 (12H, m, aromatic protons biphenyl and pyridine), 8.50 (1H, d, C6–H of 
pyridine moiety), 10.00 (1H, s, phenolic OH), 13.00 (1H, s, NH of pyridine 
moiety). 
4-(2-Amino-3-pyridyl)--2’-[(4-hydroxyphenyl)thio]-6-oxo-1,6-dihydro-2,4’-bi-
pyridine-5-carbonitrile (3i). IR (KBr, cm–1):  3450 (NH2), 2948 (ArH), 2236 
(C=N), 1675
 (C=O), 1611 (C=C), 1561 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 
6.90 (2H, d, C3–, C5–H of hydroxyphenylthio), 7.20 (2H, m, C2–, C6–H of hy-
droxyphenylthio), 7.42 (4H, m, protons of pyridines), 8.0 (1H, d, C6–H of 2-ami-
no-3-pyridyl moiety), 8.6 (1H, d, C6–H of pyridine moiety), 10.00 (1H, s, phe-
nolic OH), 13.00 (1H, s, NH of pyridine moiety). 
2’-[(4-Hydroxyphenyl)thio]-6-oxo-4-(2,3,5-trihydroxyphenyl)-1,6-dihydro-
-2,4’-bipyridine-5-carbonitrile (3j). IR (KBr, cm–1): 2922 (ArH), 2224 (C=N), 
1672 (C=O), 1589 (C=C), 1510 (C=C). 
2’-[(4-Hydroxyphenyl)thio]-4-(6-methoxy-2-naphthyl)-6-oxo-1,6-dihydro-
-2,4’-bipyridine-5-carbonitrile (3k). IR (KBr, cm–1): 2936 (ArH), 2220 (C=N), 
1658
 (C=O), 1579 (C=C), 1488 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 3.90 (3H, 
d, OCH3), 6.9–8.0 (14H, m, aromatic protons), 8.6 (1H, d, C6–H of pyridine 
moiety), 10.00 (1H, s, phenolic OH), 12.90 (1H, s, NH of pyridine moiety). 
6-Amino-4-(4-chlorophenyl)-2’-[(4-hydroxyphenyl)thio]-2,4’-bipyridine-5-car-
bonitrile (4a). IR (KBr, cm-1): 3468 (NH2), 2216 (CN), 1579 and 1494 (C=C); 
1H-NMR (DMSO-d6, δ / ppm): 6.90 (2H, d, C3–, C5–H of hydroxyphenylthio), 
7.40 (2H, d, C2–, C6–H of hydroxyphenylthio), 7.55–7.75 (7H, m, aromatic pro-
tons of pyridines and aryl moiety), 8.50 (1H, d, C6–H of pyridine moiety), 10.00 
(1H, s, phenolic OH); MS-FAB (m/z): 432 (M+1, 90 %), 431(M, 10 %). 
6-Amino-2’-[(4-hydroxyphenyl)thio]-4-(4-methoxyphenyl)-2,4’-bipyridine-5-
-carbonitrile (4b). IR (KBr, cm–1): 3425 (NH2), 2970 (CH3), 2211(C=N), 1494 
(C=C); 1H-NMR (DMSO-d6, δ / ppm): 3.85 (3H, s, OCH3), 6.85 (2H, d, C3–, 
C5–H of hydroxyphenylthio), 7.18 (2H, d, C3–, C5–H of aryl), 7.36 (4H, m, C2–, 
C6–H of hydroxyphenylthio, C2–, C6–H of aryl), 7.6 (2H, d, aromatic protons of 
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pyridine), 7.90 (1H, s, C3–H of pyridine), 8.52 (1H, d, C6–H of pyridine moiety), 
10.00 (1H, s, phenolic OH). 
6-Amino-4-(3,4-dimethoxyphenyl)-2’-[(4-hydroxyphenyl)thio]-2,4’-bipyridi-
ne-5-carbonitrile (4c). IR (KBr, cm–1): 3630 (OH), 3337 (NH2), 2970 (CH3), 
2207 (C=N), 1515 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 3.8 (3H, s, OCH3), 3.9 
(3H, s, OCH3), 6.90 (4H, m, C3–, C5–H of hydroxyphenylthio, C2–, C5–H of 
4-aryl), 7.22 (1H, d, C6–H of 4-aryl), 7.36 (3H, m, aromatic protons of pyridine), 
7.42 (2H, d, C2, C6–H of hydroxyphenylthio), 8.54 (1H, d, C6–H of pyridine), 
10.00 (1H, s, phenolic OH); MS-FAB (m/z): 457(M, 10 %). 
6-Amino-2’-[(4-hydroxyphenyl)thio]-4-(4-methylphenyl)-2,4’-bipyridine-5-car-
bonitrile (4d). IR (KBr, cm–1): 3416 (NH2), 2919 (CH3), 2206 (C=N), 1547 
(C=C); 1H-NMR (DMSO-d6, δ / ppm): 2.40 (3H, s, CH3), 6.90 (2H, d, C3–, C5–H 
of hydroxyphenylthio), 7.30 (2H, d, C2–, C6–H of hydroxyphenylthio), 7.42– 
–7.70 (7H, m, aromatic protons phenyl and pyridine), 8.60 (1H, d, C6–H of pyri-
dine moiety), 10.00 (1H, s, phenolic OH). 
6-Amino-4-(3-hydroxy-4-methoxyphenyl)-2’-[(4-hydroxyphenyl)thio]-2,4’-bi-
pyridine-5-carbonitrile (4e). IR (KBr, cm–1): 3349 (NH2), 2935 (CH3), 2199 
(C=N), 1555 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 4.0 (3H, s, OCH3), 6.90 
(2H, d, C3–, C5–H of hydroxyphenylthio), 7.30 (2H, d, C2–, C6–H of hydroxy-
phenylthio), 7.42 (6H, m, aromatic protons of aryl and pyridine), 8.65 (1H, d, 
C6–H of pyridine moiety), 10.00 (1H, s, phenolic OH); MS-FAB (m/z): 444 
(M+1, 100 %). 
6-Amino-4-(4-biphenylyl)-2’-[(4-hydroxyphenyl)thio]-2,4’-bipyridine-5-car-
bonitrile (4f). IR (KBr, cm–1): 3416 (NH2), 2954 (ArH), 2214 (C=N), 1575 
(C=C), 1490 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 6.90 (2H, d, C3–, C5–H of 
hydroxyphenylthio), 7.30 (2H, d, C2–, C6–H of hydroxyphenylthio), 7.42–7.90 
(12H, m, aromatic protons biphenyl and pyridine), 8.60 (1H, d, C6–H of pyridine 
moiety), 10.00 (1H, s, phenolic OH). 
6-Amino-4-(2-amino-3-pyridyl)-2’-[(4-hydroxyphenyl)thio]-2,4’-bipyridine- 
-5-carbonitrile (4g). IR (KBr, cm–1): 3449 (NH2), 2934 (ArH), 2197 (C=N), 
1497 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 6.90 (2H, d, C3–, C5–H of hyd-
roxyphenylthio), 7.20 (2H, m, C2–, C6–H of hydroxyphenylthio), 7.42 (4H, m, 
protons of pyridines), 8.0 (1H, d, C6–H of 2-amino-3-pyridyl moiety), 8.50 (1H, 
d, C6–H of pyridine moiety), 10.00 (1H, s, phenolic OH). 
6-Amino-2’-[(4-hydroxyphenyl)thio]-4-(2,3,5-trihydroxyphenyl)-2,4’-bipyri-
dine-5-carbonitrile (4h). IR (KBr, cm–1): 3410 (NH2), 2926 (ArH), 2210 (C=N), 
1487 (C=C); 1H-NMR (DMSO-d6, δ / ppm): 5.90 (1H, s, C4–H of 2,3,5-trihyd-
roxyphenyl), 6.16 (1H, s, C4–H of 2,3,5-trihydroxyphenyl), 6.90 (2H, d, C3–, 
C5–H of hydroxyphenylthio), 7.20 (2H, d, C2–, C6–H of hydroxyphenylthio), 
7.42 (3H, m, protons of pyridine), 8.50 (1H, d, C6–H of pyridine moiety), 10.00 
(1H, s, phenolic OH). 
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The formation 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2) was 
confirmed by FTIR, 1H-NMR, 13C-NMR and elemental analyses. The IR spec-
trum of 2 exhibited absorption bands at 3066, 1700 and 1587 cm–1 due to CH3, 
C=O and aromatic C=C stretching frequencies, respectively. Its 1H-NMR spec-
trum showed singlets at δ 2.45, 7.17 and 9.48 ppm, which are due to CH3, pyridi-
ne proton and hydroxyl proton, respectively. Further, doublets at 6.93 and 7.48 
ppm are due to the aromatic protons of the 4-hydroxyphenylthio group, while the 
doublets at 7.35 and 8.55 ppm are due to protons of the pyridine nucleus. Its 13C-
-NMR spectrum showed peaks at 26.07, 116.28, 116.73, 117.04, 117.40, 136.73, 
142.88, 149.72, 158.67, 164.48 and 196.54 ppm, which are due to CH3, C1 of 
4-hydroxyphenylthio, C3 and C5 of 4-hydroxyphenylthio, C3 of pyridine, C5 of 
pyridine, C2 and C6 of 4-hydroxyphenylthio, C4 of pyridine, C6 of pyridine, C4 of 
4-hydroxyphenylthio, C2 of pyridine and C=O, respectively. It was observed that 
the peaks due to quaternary carbons disappeared on DEPT experimentation. 
The build up of 2’-[(4-hydroxyphenyl)thio]-6-oxo-4-phenyl-2,4’-bipyridine-
-5-carbonitrile (3a) was established on the basis of FTIR, 1H-NMR, 13C-NMR, 
mass spectral and elemental analyses. Its IR spectrum exhibited peaks at 2920, 
2218, 1640 and 1590 cm–1 due to stretching frequencies of CH3, C≡N, C=O and 
C=C groups, respectively. Its 1H-NMR spectrum exhibited two doublets at δ 6.90 
and 7.41 ppm, due to the presence of the 4-hydroxyphenylthio moiety, and one 
multiplet for five protons at 7.60 ppm due to phenyl group at the position 4. Also, 
it appeared as a multiplet at 7.70 ppm, integrating for three protons, due to the 
pyridine rings and a doublet at 8.5 ppm due to the C6–H of pyridine. The OH and 
pyridine –NH protons appeared at δ 10.00 and 13.00 ppm, respectively. The LC–
–mass spectrum displayed the molecular ion peak at m/z 398.1 (M+1, 100 %), 
which is in agreement with the molecular formula C23H15N3O2S. 
The structure of 6-amino-4-chlorophenyl-2’-[(4-hydroxyphenyl)thio]-2,4’-bi-
pyridine-5-carbonitrile (4a) was established on the basis of FTIR, 1H-NMR, 
mass spectral and elemental analyses. The IR spectrum exhibited peaks at 3468, 
2216 and 1579 cm–1, which are due to the presence of NH2, CN and C=C groups, 
respectively. The 1H-NMR spectrum exhibited doublets at δ 6.90 and 7.40 ppm, 
which are due to the four protons of the 4-hydroxyphenylthio moiety. The ap-
pearance of a multiplet at 7.55–7.75 ppm is due to seven aromatic protons of the 
pyridines and aryl moiety. Furthermore, the appearance of a doublet at δ 8.50 
ppm is due to C6–H of the pyridine moiety. In addition, the proton of the hyd-
roxyl group resonates at δ 10 ppm as a broad singlet. The FAB mass spectrum 
showed the molecular ion peak at m/z 431(M+1, 100 %), which is in accordance 
with the molecular formula C23H15ClN4OS. 
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Biological screening 
Antibacterial activity. All the title compounds, 3a–k and 4a–h, were eva-
luated for their in vitro antibacterial activity against two bacteria, viz., Staphy-
lococcus aureus and Escherichia coli,  using the cup plate method.22,23 The 
solvent, N,N-dimethylformamide, showed no zone of inhibition. The activities 
were compared with the known standard drug gentamycin, used at a con-
centration of 1000 ppm. The results are summarized in Table II. 
TABLE II. Antimicrobial activity of the title compounds 
Compound 
Zone of inhibition, mm 
Antibacterial activity  Antifungal activity 
Staphylococcus 
aureus  Escherichia coli Aspergillus 
niger  Candida albicans 
3a  16 17  20  22 
3b  18 15  18  14 
3c  12 14  20  16 
3d  16 14  18  19 
3e  10 12  21  20 
3f  20 21  16  19 
3g  17 22  22  23 
3h  14 16  20  22 
3i  17 15  20  18 
3j  13 12  15  14 
3k  14 15  17  16 
4a  14 16  19  20 
4b 16  12  17  16 
4c 17  15  16  18 
4d 16  16  15  12 
4e 18  14  19  18 
4f 14  16  20  22 
4g 15  17  21  18 
4h 17  13  14  16 
Standard (flucanazole)  –  –  25  24 
Standard (gentamycin)  21 23  – – 
Results of antibacterial studies revealed that compounds 3f and 3g showed 
fairly good activity against both the strains, while compounds 4b, 4e and 4g 
showed good activity against S. aureus, and the remaining compounds exhibited 
moderate activity, compared to the standard gentamycin. The enhanced antibac-
terial activity in the compounds is attributed to the presence of 4-methylphenyl 
and 4-methoxyphenyl groups at the position 4 of the pyridine ring. 
Antifungal activity. All the title compounds, 3a–k and 4a–h, were screened 
for their in vitro antifungal activity against Aspergillus niger and Candida al-
bicans using the cup plate method.22,23 The solvent, N,N-dimethylformamide 
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showed no zone of inhibition. The activities were compared with the known 
standard drug flucanazole, used at a concentration of 1000 ppm. The results are 
tabulated in Table II. 
The results of the antifungal screening showed that compounds 3a, 3e, 3g, 
3h, 4a, 4f and 4h displayed good activity against both fungal strains, which were 
comparable with the standard flucanazole. Compounds 3b, 3c, 3d, 3k and 4e 
showed good activity against A. niger, while the remaining compounds exhibited 
moderate activity when compared to flucanazole. It was noticed that the presence 
of the phenyl, N,N-diethylamino-2-hydroxyphenyl, 4-methoxyphenyl, 4-chloro-
phenyl, 4,4’-biphenyl-1-yl and 2-amino-3-pyridyl group at position 4 of the pyri-
dine moiety led to increased antifungal activity. 
EXPERIMENTAL 
The melting points were determined in open capillaries and are uncorrected (melting 
point apparatus: Serwell Instruments Inc., India). The purity of the compounds was checked 
by thin layer chromatography (TLC) on a silica-coated aluminum sheet (silica gel 60F254) 
using chloroform and methanol (9:1, v/v). The IR spectra were recorded on a Nicolet Avatar 
330-FTIR spectrometer. The 1H- and 13C-NMR spectra were recorded on a Varian 300 MHz 
NMR spectrometer using TMS as the internal standard. The chemical shifts (δ) are reported in 
ppm and the signals are described as singlet (s), doublet (d), triplet (t), quartet (q), broad (br) 
and multiplet (m). The FAB mass spectra were recorded on a Jeol SX 102/DA-6000 spec-
trophotometer/data system using argon/xenon (6 KV, 10 mA) FAB gas, at 70 eV. Elemental 
analysis was carried out using a Flash EA 1112 Series, CHNSO analyzer (Thermo). The sol-
vents and reagents were purchased from commercial venders in the appropriate grade and 
were used without purification. 
Procedure for the preparation of 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2) 
A mixture of 12.6 g (0.10 mol) of 4-hydroxythiophenol (1) and 18.7 g (0.12 mol) of 
2-chloro-4-acetylpyridine in 10 mL pyridine was heated under reflux for 8 h. After the re-
action, the pyridine was evaporated under reduced pressure and the reaction mixture was di-
luted with water. The product was extracted with ethyl acetate and the extract was concen-
trated to 1/4
th of the volume. The resulting solution was left overnight at room temperature. 
Solid product was collected by filtration, and finally recrystallized from ethyl acetate. 
IR (KBr, cm-1): 3066 (CH3), 1700 (C=O), 1587 (Ar); 1H-NMR (CDCl3+DMSO-d6, δ / ppm): 
2.45 (3H, s, CH3), 6.93 (2H, d, C3–, C5–H of hydroxyphenylthio, J = 8.72 Hz), 7.17 (1H, s, 
C3–H of pyridine), 7.35 (2H, d, C5–H of pyridine), 7.48 (2H, d, C2–, C6–H of hydroxylphe-
nylthio), 8.55 (1H, d, C6–H of pyridine), 9.48 (1H, s, OH of phenyl); 13C-NMR (CDCl3+ 
+ DMSO-d6, δ / ppm): 26.07 (CH3), 116.28 (C1 of 4-hydroxyphenylthio), 116.73 (C3 and C5 
of 4-hydroxyphenylthio), 117.04 (C3 of pyridine), 117.4 (C5 of pyridine), 136.73 (C2 and C6 
of 4-hydroxyphenylthio), 142.88 (C4 of pyridine), 149.72 (C6 of pyridine), 158.67 (C4 of 
4-hydroxyphenylthio), 164.48 (C2 of pyridine), 196.54 (carbonyl). 
General procedure for the preparation of 4-aryl- -2’-[(4-hydroxyphenyl)thio]-6-oxo-1,6- 
-dihydro-2,4’-bipyridine-5-carbonitriles (3a–k) 
A mixture of 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2) (1.0 mmol), an aro-
matic aldehyde (1.0 mmol), ethyl cyanoacetate (1.0 mmol), ammonium acetate (4.0 mmol) 
and 5.0 mL ethanol was heated at reflux for 10 h. The reaction mixture was left overnight and 
the separated solids were filtered and recrystallized from ethanol. 
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General procedure for the preparation of 6-amino-4-aryl-2’-[(4-hydroxyphenyl)thio]-2,4’- 
-bipyridine-5-carbonitriles (4a–h) 
A mixture of 1-{2-[(4-hydroxyphenyl)thio]pyridin-4-yl}ethanone (2) (1.0 mmol), an 
aromatic aldehyde (1.0 mmol), malononitrile (1.0 mmol), ammonium acetate (4.0 mmol) and 
10 mL of ethanol was heated at reflux for 6 h. The reaction mixture was left overnight and the 
separated solids were filtered and recrystallized from ethanol. 
CONCLUSIONS 
The successful syntheses of two series of heterocyclic title compounds and 
an evaluation of the antimicrobial activity of the new pyridines containing the 
4-hydroxyphenylthio group were reported. From the results of the antimicrobial 
screening, it can be concluded that compound 3g was found to be active against 
both bacteria and fungi. The activity is due to the presence of 4-methoxyphenyl 
group in the structure. 
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ИЗВОД 
СИНТЕЗА НЕКИХ БИОЛОШКИ АКТИВНИХ 2,4’-БИПИРИДИН-5-КАРБОНИТРИЛА 
КОЈИ САДРЖЕ 4-ХИДРОКСИФЕНИЛТИО ГРУПУ 
T. KARABASANAGOUDA1, AIRODY VASUDEVA ADHIKARI2 и G. PARAMESHWARAPPA3 
1SeQuent Scientific Ltd., New Mangalore-575011, 2Department of Chemistry, National Institute of Technology 
Karnataka, Surathkal, Srinivasnagar-575025 и 3Department of Pharmaceutical Chemistry, 
Gulbarga University, Gulbarga-585106, India 
Серија  нових 4-арил-2’-[(4-хидроксифенил)тио]-6-оксо-1,6-дихидро-2,4’-бипиридин-5- 
-карбонитрила ( 3a–k)  и 6-амино-4-арил-2’-[(4-хидроксифенил)тио]-2,4’-бипиридин-5-кар-
бонитрила (4а–h) синтетизована је из 4-хидрокситиофенола (1). У реакцији 4-хидрокситио-
фенола са 4-ацетил-2-хлоропиридином добијен је 1-{2-[(4-хидроксифенил)тио]пиридин-4-ил}-
етанон (2). Tретирањем једињења 2 са етил-цијаноацетатом у присуству амонијум-ацетата са 
различитим ароматичним алдехидима добијена су једињења 3а–k. С друге стране, једињење 
2  кондензацијом  са  ароматичним  алдехидима  у  присуству  алкохолног  раствора  малоно-
нитрила у амонијум-ацетату наградило је једињења 4а–h. Структуре нових једињења утвр-
ђене се на основу елементалне анализе, IR, 1H и 13C-NMR и MS спектралних података. Aн-
тибактеријска активност насловљених једињења, као и антифунгална активност тестирана је 
in vitro на два соја, односно два типа гљивица. Нека једињења показују охрабрујућу актив-
ност. 
(Примљено 2. јуна 2008, ревидирано 26. марта 2009) 
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